{
    "company_name": "AstraZeneca",
    "file_name": "5bb5f71d1457f3272adab97d64a79c300da75cea",
    "data_points": [
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                3,
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (units/year)",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (liters/year)",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                21
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                101,
                106,
                126
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                151,
                175,
                179
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                151,
                175,
                179
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                151,
                175,
                179
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                146,
                156
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (units/year)",
            "metric_src_pdf_page": [
                146,
                156
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                102,
                175
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                108,
                175
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                102,
                175
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                110,
                176
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                104,
                110
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                106,
                175
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                106,
                175
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                151,
                179
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of drugs on the market (approved)",
            "metric_src_pdf_page": [
                204,
                206,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Global distribution network (markets served)",
            "metric_src_pdf_page": [
                220
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                220
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase I",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase III",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (units/year)",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Branded product count",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Generic product count",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Pharmacovigilance reports (adverse events logged)",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Size of sales force (year-end)",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Inventory of active pharmaceutical ingredients",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Manufacturing capacity (liters/year)",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of compounds in Phase II",
            "metric_src_pdf_page": [
                207,
                213
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Number of active pharmaceutical patents",
            "metric_src_pdf_page": [
                220
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                220
            ]
        },
        {
            "company_name": "AstraZeneca",
            "industry": "Pharmaceuticals",
            "metric_type": "Clinical trial sites operating at year-end",
            "metric_src_pdf_page": [
                220
            ]
        }
    ],
    "events": [
        {
            "event_type": "has_leadership_changes",
            "events_src_pdf_page": [
                8
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                30
            ]
        },
        {
            "event_type": "has_rnd_investment_numbers",
            "events_src_pdf_page": [
                22
            ]
        },
        {
            "event_type": "mentions_new_risk_factors",
            "events_src_pdf_page": [
                12
            ]
        },
        {
            "event_type": "has_executive_compensation",
            "events_src_pdf_page": [
                106,
                107,
                148
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                155,
                156
            ]
        },
        {
            "event_type": "has_new_product_launches",
            "events_src_pdf_page": [
                226,
                227
            ]
        },
        {
            "event_type": "has_executive_compensation",
            "events_src_pdf_page": [
                191
            ]
        },
        {
            "event_type": "has_leadership_changes",
            "events_src_pdf_page": [
                191
            ]
        },
        {
            "event_type": "has_capital_expenditures",
            "events_src_pdf_page": [
                212
            ]
        }
    ],
    "fin_metrics": [
        {
            "fin_metric_type": "total revenue",
            "fin_metrics_src_pdf_page": [
                60
            ]
        },
        {
            "fin_metric_type": "operating income",
            "fin_metrics_src_pdf_page": [
                60
            ]
        },
        {
            "fin_metric_type": "net income",
            "fin_metrics_src_pdf_page": [
                60
            ]
        },
        {
            "fin_metric_type": "shareholders' equity",
            "fin_metrics_src_pdf_page": [
                66
            ]
        },
        {
            "fin_metric_type": "earnings per share (EPS)",
            "fin_metrics_src_pdf_page": [
                66
            ]
        },
        {
            "fin_metric_type": "dividend per share",
            "fin_metrics_src_pdf_page": [
                66
            ]
        },
        {
            "fin_metric_type": "total revenue",
            "fin_metrics_src_pdf_page": [
                140,
                152,
                155
            ]
        },
        {
            "fin_metric_type": "gross profit margin",
            "fin_metrics_src_pdf_page": [
                140,
                155
            ]
        },
        {
            "fin_metric_type": "operating margin",
            "fin_metrics_src_pdf_page": [
                140,
                155
            ]
        },
        {
            "fin_metric_type": "net profit margin",
            "fin_metrics_src_pdf_page": [
                140,
                155
            ]
        },
        {
            "fin_metric_type": "net income",
            "fin_metrics_src_pdf_page": [
                140,
                155
            ]
        },
        {
            "fin_metric_type": "total assets",
            "fin_metrics_src_pdf_page": [
                141,
                156
            ]
        },
        {
            "fin_metric_type": "total liabilities",
            "fin_metrics_src_pdf_page": [
                141,
                156
            ]
        },
        {
            "fin_metric_type": "shareholders' equity",
            "fin_metrics_src_pdf_page": [
                141,
                156
            ]
        },
        {
            "fin_metric_type": "cash flow from operations",
            "fin_metrics_src_pdf_page": [
                143,
                154
            ]
        },
        {
            "fin_metric_type": "total revenue",
            "fin_metrics_src_pdf_page": [
                204,
                206,
                213
            ]
        },
        {
            "fin_metric_type": "operating margin",
            "fin_metrics_src_pdf_page": [
                204,
                206,
                213
            ]
        },
        {
            "fin_metric_type": "net income",
            "fin_metrics_src_pdf_page": [
                204,
                206,
                213
            ]
        },
        {
            "fin_metric_type": "total liabilities",
            "fin_metrics_src_pdf_page": [
                204,
                206,
                213
            ]
        },
        {
            "fin_metric_type": "total assets",
            "fin_metrics_src_pdf_page": [
                204,
                206,
                213
            ]
        },
        {
            "fin_metric_type": "shareholders' equity",
            "fin_metrics_src_pdf_page": [
                204,
                206,
                213
            ]
        }
    ]
}